BeiGene, Ltd. 4
4 · BeiGene, Ltd. · Filed Jun 29, 2017
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Li Ji
EVP and Gl. Head of Bus. Dev.
Transactions
- Award
Share Option (Right to Buy)
2017-06-27+750,000→ 750,000 totalExercise: $3.49Exp: 2027-06-26→ Ordinary Shares (750,000 underlying)
Footnotes (2)
- [F1]The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares.
- [F2]The options vest over a four-year period as follows: 25% on the first anniversary of the date of grant, with the remaining shares vesting in 36 equal successive monthly installments on the last day of each month thereafter.